LSTA · Lisata Therapeutics, Inc. · Documents
$1.67
-0.23 (-12.11%)
At close · Sep 10
Going-concern doubt
— flagged Aug 6, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Based on our current business plan and existing capital resources, management has concluded that there is substantial doubt regarding our ability to continue as a going concern for a period of twelve months from the date of issuance of the accompanying consolidated financial statements.”View the 10-Q filed Aug 6, 2026
Market Cap
$17.12M
Shares
9.01M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 10-Q | 2026-08-06 | 2026-06-30 | |
| 8-K | 2026-08-04 | 2026-08-03 | |
| 8-K | 2026-07-24 | — | |
| 8-K | 2026-07-17 | 2026-07-16 | |
| 8-K | 2026-06-09 | 2026-06-08 | |
| 8-K | 2026-06-01 | — | |
| 8-K | 2026-05-29 | — | |
| 10-Q | 2026-05-11 | 2026-03-31 | |
| 8-K | 2026-05-04 | 2026-05-03 | |
| 10-K/A | 2026-04-28 | 2025-12-31 | |
| 8-K | 2026-04-15 | — | |
| 8-K | 2026-04-03 | 2026-04-02 | |
| 10-K | 2026-03-12 | 2025-12-31 | |
| 8-K | 2026-03-09 | 2026-03-06 | |
| 8-K | 2026-02-27 | — | |
| 8-K | 2026-01-27 | — | |
| 8-K | 2026-01-21 | 2026-01-20 | |
| 8-K | 2025-11-06 | — | |
| 10-Q | 2025-11-06 | 2025-09-30 | |
| 8-K | 2025-10-14 | — | |
| 8-K | 2025-10-08 | — | |
| 8-K | 2025-08-07 | — | |
| 10-Q | 2025-08-07 | 2025-06-30 | |
| 8-K | 2025-07-15 | — | |
| 8-K | 2025-06-26 | — | |
| 8-K | 2025-06-17 | — | |
| 8-K | 2025-06-13 | 2025-06-10 | |
| 8-K | 2025-06-10 | — | |
| 8-K | 2025-05-08 | — | |
| 10-Q | 2025-05-08 | 2025-03-31 | |
| DEF 14A | 2025-04-25 | — | |
| 8-K | 2025-02-27 | — | |
| 10-K | 2025-02-27 | 2024-12-31 | |
| 8-K | 2025-01-23 | 2025-01-22 | |
| 8-K | 2024-12-03 | — | |
| 8-K | 2024-11-12 | — | |
| 10-Q | 2024-11-12 | 2024-09-30 | |
| 8-K | 2024-08-12 | — | |
| 10-Q | 2024-08-12 | 2024-06-30 | |
| 8-K | 2024-06-27 | — | |
| 10-Q | 2024-05-09 | 2024-03-31 | |
| 8-K | 2024-05-09 | — | |
| DEF 14A | 2024-04-29 | — | |
| 8-K | 2024-04-17 | 2024-04-15 | |
| 8-K | 2024-02-29 | — | |
| 10-K | 2024-02-29 | 2023-12-31 | |
| 8-K | 2023-11-02 | — | |
| 10-Q | 2023-11-02 | 2023-09-30 | |
| 8-K | 2023-08-14 | — | |
| 10-Q | 2023-08-14 | 2023-06-30 |
Showing 1–50 of 113 filings
Key facts
CIK
320017
CUSIP
128058302
13F (30d)
22 filings
22 filers
Visit website
Investor relations